HITK Financial Facts
Income from continuing operations before income tax expense: 12.31MDILUTED INCOME PER SHARE: 0.59
See Full Income Statement
LIABILITIES AND STOCKHOLDERS' EQUITY: 300.68M
Commitments and Contingencies (Note 13): 0
See Full Balance Sheet
Hi Tech Pharmacal Co. Inc. (HITK) Earnings
|
Expand Research on HITK
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +10.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/9/13  |
 |
Q413 | $0.50 | $0.63 | -$0.13 | $58.5M | $66.33M | N/A |  | | Details |
| 3/11/14 | Q314 | $0.75 | $0.66 | +$0.09 | $59.9M | $62.35M | N/A | | | Details | |
| 3/7/13 |
|
Q313 | $0.43 | $0.71 | -$0.28 | $64.33M | $60.45M | N/A | | | Details |
| 12/10/13 |
Q214 | $0.71 | $0.48 | +$0.23 | $58.6M | $57.97M | N/A | | | Details | |
| 7/10/12 |
|
Q412 | $0.73 | $0.78 | -$0.05 | $61.3M | $57.94M | N/A | | | Details |
| 9/9/13 |
Q114 | $0.44 | $0.44 | $0.00 | $50.5M | $57.78M | N/A | | | Details | |
| 9/5/12 |
Q113 | $0.44 | $0.68 | -$0.24 | $52M | $57.6M | N/A | | | Details | |
| 12/6/12 |
|
Q213 | $0.66 | $0.59 | +$0.07 | $57.54M | $56.89M | N/A | | | Details |
